LIVE · CORPUS
SnitchScore · reading…
evidence coverage · reading…
Coverage — measured
- Ownership hops held
- 130
An absent edge means not yet observed — never does not exist.
Legal entityHigh
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. — US company (sec:0001743881). UBO chain traced 130 hops, 42 owners, 2 holdings. Every claim linked to its source.
The finding
Ownership resolves 130 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
/01
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
Owners / controllers
- BridgeBio Pharma, Inc.
- Viking Global Opportunities Illiquid Investments Sub-Master LP· 10% owner· via SEC EDGAR (Form 3/4/5)
Holdings / subsidiaries
- BridgeBio Pharma, Inc.
Walk the full UBO chain
130 hops lockedDOSSIER
130-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Verified Dossier€29
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on BridgeBio Pharma, Inc., resolved and sourced — yours to keep, no subscription.
INCLUDED WHEN YOU UNLOCK
- UBO traceDOSSIER
- Live adverse-media scan on unlockDOSSIER
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
WHAT YOU CAN SEEFREE
YOURS NOW · FREE
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
YOURS AFTER YOU UNLOCK · PAID
3 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Adverse-media & person enrichmentDOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
/02
People & control
43 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- AGUIAR ERICAlso holds roles at 12 other companies
- Biomea Fusion, Inc.director
- INVITAE CORPdirector
- EIDOS THERAPEUTICS, INC.director
- COOK JENNIFER E.Also holds roles at 2 other companies
- Denali Therapeutics Inc.director
- Jazz Pharmaceuticals plcdirector
- Dachille Douglas A.Also holds roles at 3 other companies
- PNC FINANCIAL SERVICES GROUP, INC.director
- Equitable Holdings, Inc.director
- AMERICAN INTERNATIONAL GROUP, INC.officer
- EIDOS THERAPEUTICS, INC.Also holds roles at 23 other companies
- VALLE FRANCOofficer
- FOX JONATHAN Cofficer
- HOOPER SUZANNE SAWOCHKAdirector
- HALVORSEN OLE ANDREASAlso holds roles at 29 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- Hassan FredAlso holds roles at 10 other companies
- PRECIGEN, INC.director
- EyePoint Pharmaceuticals, Inc.director
- BIOZONE PHARMACEUTICALS, INC.director
- Helix Acquisition Corp. IIAlso holds roles at 32 other companies
- Holman Albert A IIIdirector
- Helix Holdings II LLC10% owner
- Chen Bihua10% owner
- HENDERSON MICHAEL THOMASAlso holds roles at 4 other companies
- Apogee Therapeutics, Inc.officer
- Spyre Therapeutics, Inc.director
- Apogee Therapeutics, Inc.director
- HOMCY CHARLES JAlso holds roles at 12 other companies
- Maze Therapeutics, Inc.director
- PLIANT THERAPEUTICS, INC.director
- POPULATION HEALTH INVESTMENT CO., INC.director
- KKR & Co. Inc.Also holds roles at 104 other companies
- KRAVIS HENRY Rofficer
- BARAKETT TIMOTHY Rdirector
- Crescent Energy Co10% owner
- KKR Group Co. Inc.Also holds roles at 20 other companies
- Crescent Energy Co10% owner
- KKR Real Estate Select Trust Inc.10% owner
- KKR Real Estate Select Trust Inc.tenpercentowner
- KKR Group Holdings Corp.Also holds roles at 39 other companies
- Crescent Energy Co10% owner
- KKR Real Estate Select Trust Inc.10% owner
- OneStream, Inc.tenpercentowner
- KKR Group Partnership L.P.Also holds roles at 60 other companies
- Crescent Energy Co10% owner
- KKR Real Estate Select Trust Inc.10% owner
- OneStream, Inc.tenpercentowner
- KKR MANAGEMENT HOLDINGS CORPAlso holds roles at 8 other companies
- KKR REAL ESTATE FINANCE TRUST INC.tenpercentowner
- FOCUS FINANCIAL PARTNERS INC.tenpercentowner
- GoDaddy Inc.tenpercentowner
- KKR MANAGEMENT HOLDINGS L.P.Also holds roles at 8 other companies
- KKR REAL ESTATE FINANCE TRUST INC.tenpercentowner
- FOCUS FINANCIAL PARTNERS INC.tenpercentowner
- GoDaddy Inc.tenpercentowner
- KKR Management LLPAlso holds roles at 61 other companies
- Crescent Energy Co10% owner
- KKR Real Estate Select Trust Inc.10% owner
- BrightSpring Health Services, Inc.tenpercentowner
- KRAVIS HENRY RAlso holds roles at 73 other companies
- KKR & Co. Inc.officer
- Crescent Energy Co10% owner
- KKR Real Estate Select Trust Inc.10% owner
- Kumar NeilAlso holds roles at 6 other companies
- Helix Acquisition Corp. IIdirector
- Maze Therapeutics, Inc.director
- LIANBIOdirector
- LO ANDREWAlso holds roles at 10 other companies
- AbCellera Biologics Inc.director
- Roivant Sciences Ltd.director
- Arbutus Biopharma Corpother
- MCCORMICK FRANKAlso holds roles at 4 other companies
- Helix Acquisition Corp. IIdirector
- Olema Pharmaceuticals, Inc.director
- ADURO BIOTECHdirector
- MOMTAZEE JAMES CAlso holds roles at 11 other companies
- Roivant Sciences Ltd.director
- ALLIANCE HEALTHCARE SERVICES, INCdirector
- MONTES ARCHIMEDES ACQUISITION CORPdirector
- Ott David C.Also holds roles at 29 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- ROBERTS GEORGE RAlso holds roles at 72 other companies
- Crescent Energy Co10% owner
- KKR Real Estate Select Trust Inc.10% owner
- KKR Real Estate Select Trust Inc.tenpercentowner
- SATVAT ALI J.Also holds roles at 4 other companies
- Coherus BioSciences, Inc.director
- IMPEL NEUROPHARMA INCdirector
- EIDOS THERAPEUTICS, INC.director
- SAUNDERS BRENT LAlso holds roles at 15 other companies
- Bausch & Lomb Corpofficer
- Bausch & Lomb Corpdirector
- ARS Pharmaceuticals, Inc.director
- SCHELLER RICHARD HAlso holds roles at 7 other companies
- Maze Therapeutics, Inc.director
- GENENTECH INCofficer
- Alector, Inc.director
- SCOTT RANDAL WAlso holds roles at 6 other companies
- INVITAE CORPdirector
- SLIPCHIP CORPdirector
- INVITAE CORPofficer
- Shabet Rose SharonAlso holds roles at 25 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- SINHA UMAAlso holds roles at 3 other companies
- PROKIDNEY CORP.director
- EIDOS THERAPEUTICS, INC.director
- EIDOS THERAPEUTICS, INC.officer
- Turtle CameronAlso holds roles at 5 other companies
- Spyre Therapeutics, Inc.officer
- Spyre Therapeutics, Inc.director
- Galecto, Inc.director
- Valantine HannahAlso holds roles at 2 other companies
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.director
- CareDx, Inc.director
- VIKING GLOBAL EQUITIES MASTER LTD.Also holds roles at 11 other companies
- APi Group Corptenpercentowner
- Roivant Sciences Ltd.tenpercentowner
- Adaptive Biotechnologies Corptenpercentowner
- VIKING GLOBAL INVESTORS LPAlso holds roles at 29 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- Viking Global Opportunities GP LLCAlso holds roles at 27 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- Viking Global Opportunities Illiquid Investments Sub-Master LPAlso holds roles at 26 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- Viking Global Opportunities Parent GP LLCAlso holds roles at 14 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- Viking Global Opportunities Portfolio GP LLCAlso holds roles at 27 other companies
- ACUREN CORP10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- ACUREN CORPtenpercentowner
- VIKING GLOBAL PERFORMANC LLCAlso holds roles at 17 other companies
- APi Group Corptenpercentowner
- Roivant Sciences Ltd.tenpercentowner
- Adaptive Biotechnologies Corptenpercentowner
- VIKING LONG FUND GP LLCAlso holds roles at 14 other companies
- Roivant Sciences Ltd.tenpercentowner
- Adaptive Biotechnologies Corptenpercentowner
- UROVANT SCIENCES LTD.other
- VIKING LONG FUND MASTER LTD.Also holds roles at 15 other companies
- Roivant Sciences Ltd.tenpercentowner
- Adaptive Biotechnologies Corptenpercentowner
- MYOVANT SCIENCES LTD.other
43 parties · 0 current. Ceased and resigned records are retained as history.
/03
Adverse media
Live scan on unlockDOSSIER
A live GDELT news scan for this entity's name (last 18 months) runs the moment you unlock. Matches are investigative leads by name and may come back empty.
/04
Common questions
- Who owns BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc.'s risk level?
- Where does BridgeBio Pharma, Inc. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for BridgeBio Pharma, Inc. — nothing is disclosed before that.